New Data Demonstrates Safety and Tolerability Profile of Tivozanib in Patients with Advanced Kidney Cancer
Everyone's Blog Posts - Onco'Zine,
Results from the Phase III TIVO-1 trial (TIvozanib Versus sOrafenib in 1st line advanced RCC) demonstrating the safety and…